Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2013
07/18/2013US20130184257 Piperidinyl-substituted lactams as gpr119 modulators
07/18/2013US20130184251 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
07/18/2013US20130184248 Novel compounds
07/18/2013US20130184241 Naphthalene Derivative
07/17/2013EP2615087A2 Phenylalanine derivatives
07/17/2013EP2615086A1 2,4-Diaminoquinazolines for the treatment of spinal muscular atrophy
07/17/2013EP2615084A1 Prostaglandin d synthase inhibitory piperidine compounds
07/17/2013EP2614051A2 P53-mdm2 antagonists
07/17/2013EP2613785A1 Heteroarylmethyl amides
07/17/2013CN103209976A 1-(heterocyclic carbonyl)-2-substituted pyrrolidines
07/17/2013CN103209975A Substituted bipyridines for use in organic light-emitting devices
07/17/2013CN103209964A Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
07/17/2013CN103209963A 2-quinolinyl-acetic acid derivatives as HIV antiviral compounds
07/17/2013CN103209962A Substituted 6-amino-nicotinamides as kcnq2/3 modulators
07/17/2013CN103209960A Sulfonamide compounds useful as CYP17 inhibitors
07/17/2013CN103204863A 2, 2'-bi-pyridine amine copper complex and application thereof in 2-imidazoline derivative synthesis
07/17/2013CN103204844A Amino heteroaryl compound, and preparation method and application thereof
07/17/2013CN103204843A Crystalline Ilaprazole sodium ethylate and preparation method thereof
07/17/2013CN103204842A Crystalline Ilaprazole sodium hydrate and preparation method thereof
07/17/2013CN103204841A Omeprazole sodium and preparation method
07/17/2013CN103204817A Preparation method for 4-cyanoquinoline derivatives
07/17/2013CN103204815A 4-(4-cyano-2-thioaryl)dihydropyrimidinones And Use Thereof
07/17/2013CN103204813A Condensed imidazole derivatives as TRPV3 antagonist
07/17/2013CN103204811A Process For Production Of Anthranilamide Compound
07/17/2013CN102633775B Method for preparing alpha-crystal-form imatinib mesylate
07/17/2013CN102367248B Sparfloxacin hemisulphate, its preparation method and application
07/17/2013CN102093340B Preparation method and application of 2-methylindazole derivatives
07/17/2013CN101998951B Acylthiourea compound or salt thereof, and use thereof
07/17/2013CN101821253B Piperidine derivative
07/17/2013CN101743240B ((Phenyl)imidazolyl)methylheteroaryl compounds
07/17/2013CN101663270B Quaternary ammonium compounds useful as muscarinic receptor antagonists
07/17/2013CN101641339B Compounds for the prevention and treatment of cardiovascular diseases
07/17/2013CN101622242B Bicyclic derivatives as CETP inhibitors
07/17/2013CN101607956B Method for splitting chiral medicine of hydrochloric acid lomefloxacin
07/17/2013CN101578279B Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
07/17/2013CN101531654B Preparation method for Rupatadine
07/17/2013CN101528695B Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds
07/17/2013CN101490036B Factor xa inhibitors
07/17/2013CN101460168B Benzoimidazol-2-yl pyridines as modulators of the histamine h4 receptor
07/17/2013CN101454310B Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
07/17/2013CN101420955B Dihydrodiazepines useful as inhibitors of protein kinases
07/17/2013CN101415683B New compounds
07/17/2013CN101203495B Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase MET
07/16/2013US8487116 Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
07/16/2013US8487106 Process for preparation of 2-methyl-2′-phenylpropionic acid derivatives and novel intermediate compounds
07/16/2013US8486979 Analgesics; central nervous system disorders; attentiondeficit disorders;cognition activators; bipolar disorders; Alzheimer's disease; Down's syndrome; brain disorders
07/16/2013US8486975 Non-nucleoside reverse transcriptase inhibitors
07/16/2013US8486951 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
07/16/2013US8486950 Janus kinase inhibitor compounds and methods
07/16/2013CA2741575C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
07/16/2013CA2741412C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
07/16/2013CA2699674C 5-ht7 receptor antagonists
07/16/2013CA2697167C Benzimidazole derivatives used as fxr agonists
07/16/2013CA2650627C Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
07/16/2013CA2583983C Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
07/16/2013CA2576290C Method for the production of dihydropteridinones
07/16/2013CA2569826C Substituted 2-alkyl quinazolinone derivatives as parp inhibitors
07/11/2013WO2013103150A1 Acid adduct salt of substituted pyridine compound
07/11/2013WO2013102929A1 Novel compounds for treatment of diabetes, obesity or related disorders
07/11/2013WO2013102897A1 Polymorphs of perampanel
07/11/2013WO2013102826A1 N-aminosulfonyl benzamides
07/11/2013WO2013102655A1 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b
07/11/2013WO2013024358A3 Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (cetp) inhibitors
07/11/2013US20130178631 Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
07/11/2013US20130178630 Process for making hcv protease inhibitors
07/11/2013US20130178625 P 2 x 4 receptor antagonist
07/11/2013US20130178502 Pyridine Compounds for Controlling Invertebrate Pests I
07/11/2013US20130178499 Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors
07/11/2013US20130178498 Bicyclic heteroaryl inhibitors of pde4
07/11/2013US20130178480 Inhibitors of Advanced Glycation End Products
07/11/2013US20130178478 Pyridazine amide compounds
07/11/2013US20130178475 sGC STIMULATORS
07/11/2013US20130178461 Inhibitors of bruton's tyrosine kinase
07/11/2013US20130178459 Tricyclic compounds and pbk inhibitors containing the same
07/11/2013US20130178458 Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine m1 receptors
07/11/2013US20130178457 Cannabinoid receptor modulators
07/11/2013US20130178456 Arylethynyl derivatives
07/11/2013US20130178443 Phenylquinazoline derivatives
07/11/2013US20130178417 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
07/11/2013US20130177632 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
07/11/2013US20130177535 Wnt inhibitors for human stem cell differentiation
07/11/2013US20130177529 Pyrazole Compounds
07/10/2013EP2612859A1 Method for producing 1-triazole-2-butanol derivative
07/10/2013EP2612852A1 Theramutein modulators
07/10/2013EP2611806A1 Deuterium-enriched heterocyclic compounds as kinase inhibitors
07/10/2013EP2611790A1 Pyridinones/pyrazinones, method of making, and method of use thereof
07/10/2013EP2611789A1 Quinazoline compounds and methods of use thereof
07/10/2013EP2611788A2 Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use
07/10/2013EP2611785A1 N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamides and use thereof as herbicides
07/10/2013EP2611778A1 Guanidine compounds and compositions for the inhibition of nampt
07/10/2013EP2611772A1 2 - (benzyloxy) benzamides as lrrk2 kinase inhibitors
07/10/2013EP2611502A1 Adenosine a3 receptor modulating compounds and methods of use thereof
07/10/2013EP2611300A1 Substituted fused pyrimidinones and dihydropyrimidinones
07/10/2013EP2611297A1 Fungicidal pyrazoles
07/10/2013CN1990473B Tri-substituted 1H-imidazoles compounds, preparation method and pharmaceutical composition and pharmacy use thereof
07/10/2013CN103201275A Salt(s) of 7-cyclopentyl-2 -(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
07/10/2013CN103201274A Pyrrolidine derivatives used as cathepsin inhibitors
07/10/2013CN103201273A Novel compounds for organic electronic material and organic electroluminescent device using the same
07/10/2013CN103201267A Ampk-activating heterocyclic compounds and methods for using the same
07/10/2013CN103201265A Novel microbiocides
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 1080